ask="N/A"
ask_size="N/A"
average_daily_volume="1128560"
bid="N/A"
bid_size="N/A"
book_value="-0.15"
change="-0.02"
change_from_200_day_moving_average="-0.00"
change_from_50_day_moving_average="-0.01"
change_from_52_week_high="-1.08"
change_From_52_week_low="0.26"
change_in_percent="-4.26%"
close="0.45"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.65"
ebitda="-18.11M"
eps_estimate_current_year="-0.55"
eps_estimate_next_quarter="-0.09"
eps_estimate_next_year="-0.45"
ex_dividend_date="N/A"
float_shares="48944000"
high="0.47"
high_52_weeks="1.53"
last_trade_date="3/7/2017"
last_trade_price="0.45"
last_trade_size="1300"
last_trade_time="4:02pm"
low="0.45"
low_52_weeks="0.19"
market_capitalization="30.47M"
moving_average_200_day="0.45"
moving_average_50_day="0.46"
name="BioPharmX Corporation. Common"
notes="N/A"
one_year_target_price="3.00"
open="0.46"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-1.00%"
percent_change_from_50_day_moving_average="-1.11%"
percent_change_from_52_week_high="-70.59%"
percent_change_from_52_week_low="+138.98%"
previous_close="0.47"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="265.23"
revenue="119999.00"
shares_outstanding="67719000"
short_ratio="2.01"
stock_exchange="ASE"
symbol="BPMX"
volume="688572"
weeks_range_52="0.19 - 1.53"
